LYVROAccount

Smoking cessation · Topic

Evidence-based cessation treatments

What clinical guidance recommends, in general terms, and where guidance remains unsettled.

Established guidance

Summarises public-health guidance from CDC and the National Cancer Institute, and clinical guidance from the bodies linked below. It describes what guidance says, not what is right for one person.

Counseling and medication together

USPSTF recommends behavioral interventions and FDA-approved cessation pharmacotherapy for nonpregnant adults who use tobacco. For pregnant persons, it recommends behavioral interventions; evidence is insufficient to determine the balance of benefits and harms of cessation pharmacotherapy. Insufficient evidence is not proof of ineffectiveness or an absolute contraindication.

For nonpregnant adults, USPSTF describes benefits from combining behavioral support with medication. LYVRO summarises guidance; it does not prescribe or select a treatment for anyone.

The main options, in general terms

Approved medicines for stopping smoking include nicotine replacement in several forms, varenicline and bupropion. Behavioral support includes individual and group counseling, telephone quitline coaching and text-based programmes.

Choice depends on health history, other medicines, pregnancy, cost and personal preference. That conversation belongs with a clinician or pharmacist, and it is reasonable to ask about more than one option.

What guidelines do not settle

Guideline recommendations describe average benefit across studied populations. They do not predict how any one person will respond, and they do not replace clinical judgment about an individual.

Reading the guideline itself is worthwhile when a decision matters. The sources linked below are the documents, not summaries of them.

Under study: e-cigarettes and newer nicotine products as quitting aids

Exploratory · under study

Guidance from different bodies is not aligned and the evidence continues to change. LYVRO does not present e-cigarettes as a recommended cessation treatment and this topic gives no product advice. If you are considering one, raise it with a clinician who can weigh your history.

Guided reading

Try it yourself

Sources & next steps 3 resources

These primary public resources support this topic. Guideline documents are listed separately so a patient leaflet is never mistaken for a guideline.

Named on this page

Related reading 1
Suggested searches 2

Taking a question across opens the workspace with that exact wording in the question box and removes it from the address bar. Nothing is submitted automatically: the search runs only if you submit it there.

Open the evidence workspace

Suggestions are questions, not verified evidence. No search runs automatically. Discover is public. General research requires a signed-in, nonblocked account. Restricted professional capabilities require separate authorization.

Recommended next steps 2
Additional sources and guidance 2

Each source is labeled by audience and document type. Public education and support resources are distinct from clinical guidance; inclusion does not imply clinician review.

Continue with an evidence search · Choose discovery interests

Source checks are editorial checks, not clinician verification. 3 sources in this selection. Program eligibility and local availability must be confirmed with the provider. Saving discovery resources requires the reviewed private-storage release, so nothing here is saved to an account.

The publication date is the one the publisher states on the page LYVRO links to. Where a publisher states none, the entry says so rather than showing an estimate or a date LYVRO chose. The link check date is the day an editor last opened this entry's destination and confirmed it resolved. That is an editorial check of a link. It is not proof that the external page has not changed since, and it is not clinician verification.

Editorial summary. Sources were checked on this date. LYVRO content has not been reviewed by a clinician. Read trust & methodology for how LYVRO checks the evidence workspace.